A widely available and affordable drug has been shown to be effective in treating seriously ill COVID-19 patients, according to a new international study led by researchers at the Australian National University (ANU) in collaboration with King’s College London.
The study analyzed data from almost 500 patients hospitalized with COVID-19 across six countries. Patients who inhaled heparin were half as likely to require ventilation and had a significantly lower risk of dying compared with those…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply